Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2245 to 2247 of 2247 entries
Sorted by: Best Match Show Resources per page
Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403.

Journal of radiation research

Matsuo Y, Nagata Y, Wakabayashi M, Ishikura S, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Hiraoka M.
PMID: 34350956
J Radiat Res. 2021 Sep 13;62(5):901-909. doi: 10.1093/jrr/rrab065.

This study aimed to evaluate the impact of pretreatment C-reactive protein (CRP) and skeletal muscle mass (SMM) on outcomes after stereotactic body radiotherapy (SBRT) for T1N0M0 non-small cell lung cancer (NSCLC) as a supplementary analysis of JCOG0403. Patients were...

Cite
Matsuo Y, Nagata Y, Wakabayashi M, et al. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403. J Radiat Res. 2021;62(5):901-909doi: 10.1093/jrr/rrab065.
Matsuo, Y., Nagata, Y., Wakabayashi, M., Ishikura, S., Onishi, H., Kokubo, M., Karasawa, K., Shioyama, Y., Onimaru, R., & Hiraoka, M. (2021). Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403. Journal of radiation research, 62(5), 901-909. https://doi.org/10.1093/jrr/rrab065
Matsuo, Yukinori, et al. "Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403." Journal of radiation research vol. 62,5 (2021): 901-909. doi: https://doi.org/10.1093/jrr/rrab065
Matsuo Y, Nagata Y, Wakabayashi M, Ishikura S, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Hiraoka M. Impact of pre-treatment C-reactive protein level and skeletal muscle mass on outcomes after stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer: a supplementary analysis of the Japan Clinical Oncology Group study JCOG0403. J Radiat Res. 2021 Sep 13;62(5):901-909. doi: 10.1093/jrr/rrab065. PMID: 34350956; PMCID: PMC8438483.
Copy Download .nbib Format: NLM
First report of watermelon crinkle leaf-associated virus 1 and 2 infecting watermelon (Citrullus lanatus) plants in Brazil.

Plant disease

Maeda MHK, Koyama LHH, Campos RNS, Kauffmann CM, Osse de Souza J, Gilbertson R, Inoue-Nagata A, Freitas DMS, Nogueira DRS, Melo FL, Nagata T.
PMID: 34455800
Plant Dis. 2021 Aug 29; doi: 10.1094/PDIS-06-21-1325-PDN. Epub 2021 Aug 29.

Watermelon (Citrullus lanatus) is an important crop in Brazil both for export and domestic consumption. In this study, the cause of a severe leaf curling, distortions and vein clearing/yellowing disease of watermelon was investigated by high-throughput sequencing (HTS). The...

Cite
Maeda MHK, Koyama LHH, Campos RNS, et al. First report of watermelon crinkle leaf-associated virus 1 and 2 infecting watermelon (Citrullus lanatus) plants in Brazil. Plant Dis. 2021;doi: 10.1094/PDIS-06-21-1325-PDN.
Maeda, M. H. K., Koyama, L. H. H., Campos, R. N. S., Kauffmann, C. M., Osse de Souza, J., Gilbertson, R., Inoue-Nagata, A., Freitas, D. M. S., Nogueira, D. R. S., Melo, F. L., & Nagata, T. (2021). First report of watermelon crinkle leaf-associated virus 1 and 2 infecting watermelon (Citrullus lanatus) plants in Brazil. Plant disease, . https://doi.org/10.1094/PDIS-06-21-1325-PDN
Maeda, Matheus Hideki Kihara, et al. "First report of watermelon crinkle leaf-associated virus 1 and 2 infecting watermelon (Citrullus lanatus) plants in Brazil." Plant disease vol. (2021). doi: https://doi.org/10.1094/PDIS-06-21-1325-PDN
Maeda MHK, Koyama LHH, Campos RNS, Kauffmann CM, Osse de Souza J, Gilbertson R, Inoue-Nagata A, Freitas DMS, Nogueira DRS, Melo FL, Nagata T. First report of watermelon crinkle leaf-associated virus 1 and 2 infecting watermelon (Citrullus lanatus) plants in Brazil. Plant Dis. 2021 Aug 29; doi: 10.1094/PDIS-06-21-1325-PDN. Epub 2021 Aug 29. PMID: 34455800.
Copy Download .nbib Format: NLM
Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer.

Molecular and clinical oncology

Nagata T, Kanamori M, Sekine S, Arai M, Moriyama M, Fujii T.
PMID: 33796292
Mol Clin Oncol. 2021 May;14(5):103. doi: 10.3892/mco.2021.2265. Epub 2021 Mar 17.

Modulated electro-hyperthermia (mEHT) is a new treatment modality developed to overcome the problems associated with traditional hyperthermia; mEHT uses a precise impedance-matched system and modulated radiofrequency current flow to malignant tumors. It selects the malignant cells based on their...

Cite
Nagata T, Kanamori M, Sekine S, et al. Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Mol Clin Oncol. 2021;14(5):103doi: 10.3892/mco.2021.2265.
Nagata, T., Kanamori, M., Sekine, S., Arai, M., Moriyama, M., & Fujii, T. (2021). Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Molecular and clinical oncology, 14(5), 103. https://doi.org/10.3892/mco.2021.2265
Nagata, Takuya, et al. "Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer." Molecular and clinical oncology vol. 14,5 (2021): 103. doi: https://doi.org/10.3892/mco.2021.2265
Nagata T, Kanamori M, Sekine S, Arai M, Moriyama M, Fujii T. Clinical study of modulated electro-hyperthermia for advanced metastatic breast cancer. Mol Clin Oncol. 2021 May;14(5):103. doi: 10.3892/mco.2021.2265. Epub 2021 Mar 17. PMID: 33796292; PMCID: PMC8010507.
Copy Download .nbib Format: NLM
Showing 2245 to 2247 of 2247 entries